Invention Grant
- Patent Title: Counteracting drug-induced obesity using GLP-1 agonists
- Patent Title (中): 使用GLP-1激动剂抵消药物引起的肥胖
-
Application No.: US11629238Application Date: 2005-05-31
-
Publication No.: US08410047B2Publication Date: 2013-04-02
- Inventor: Camilla Bock , Sanne Møller Knudsen , Karin Rimvall
- Applicant: Camilla Bock , Sanne Møller Knudsen , Karin Rimvall
- Applicant Address: DK Bagsvaerd
- Assignee: Novo Nordisk A/S
- Current Assignee: Novo Nordisk A/S
- Current Assignee Address: DK Bagsvaerd
- Agent Michael J. Brignati
- Priority: DK200400911 20040611
- International Application: PCT/EP2005/052475 WO 20050531
- International Announcement: WO2005/120492 WO 20051222
- Main IPC: A61P3/04
- IPC: A61P3/04 ; A61K38/26
Abstract:
The present invention describes administering a GLP-1 agonist to treat obesity caused by the administration of an obesity-inducing drug.
Public/Granted literature
- US20090054315A1 Counteracting Drug-Induced Obesity Using GLP-1 Agonists Public/Granted day:2009-02-26
Information query
